HUSSMAN STRATEGIC ADVISORS, INC. CPRX — CATALYST PHARMACEUTICALS INC

Ownership history in HUSSMAN STRATEGIC ADVISORS, INC.  ·  20 quarters on record

AI Ownership Summary

HUSSMAN STRATEGIC ADVISORS, INC. reported CATALYST PHARMACEUTICALS INC (CPRX) in 20 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 0.73% in 2025 Q2. The latest visible filing shows CPRX at 0.45% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CPRX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was HUSSMAN STRATEGIC ADVISORS, INC.'s position in CATALYST PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CPRX was reported at 0.45% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.73% in 2025 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CPRX stock page HUSSMAN STRATEGIC ADVISORS, INC. fund profile HUSSMAN STRATEGIC ADVISORS, INC. full holdings
How HUSSMAN STRATEGIC ADVISORS, INC. held CPRX — position size vs. price
% of Fund (quarterly)    CPRX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 84,000 -21,000 -20.0% 0.45% $2.1M 2026-05-11 $31.15
2025 Q4 REDUCED 28.6% +6.1% ❌ 105,000 -42,000 -28.6% 0.59% $2.5M 2026-02-02 $25.00
2025 Q3 UNCHANGED — — — 147,000 — 0% 0.63% $2.9M 2025-11-03 $21.44
2025 Q2 ADDED — — — 147,000 +63,000 +75.0% 0.73% $3.2M 2025-08-05 $22.22
2025 Q1 REDUCED 20.0% -10.5% ✅ 84,000 -21,000 -20.0% 0.49% $2.0M 2025-05-05 $24.30
2024 Q4 UNCHANGED — — — 105,000 — 0% 0.65% $2.2M 2025-02-03 $22.62
2024 Q3 UNCHANGED — — — 105,000 — 0% 0.51% $2.1M 2024-11-01 $21.89
2024 Q2 UNCHANGED — — — 105,000 — 0% 0.45% $1.6M 2024-08-01 $16.93
2024 Q1 REDUCED 33.3% -1.1% ✅ 105,000 -52,500 -33.3% 0.39% $1.7M 2024-05-01 $15.20
2023 Q4 UNCHANGED — — — 157,500 — 0% 0.60% $2.6M 2024-02-01 $14.43
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding CPRX

As of 2026 Q1 — sorted by position size

TANAKA CAPITAL MANAGEMENT INC 3Y 7Y 4.69% GABLES CAPITAL MANAGEMENT INC. 3Y 7Y 4.45% JW Asset Management, LLC 3Y 7Y 3.95% Ishara Investments LP 1.92% Knott David M Jr 3Y 1.77% GLOBEFLEX CAPITAL L P 3Y 7Y 1.69% Sidoxia Capital Management, LLC 1.52% Advisors Preferred, LLC 3Y 7Y 1.39% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.15% Bridge City Capital, LLC 3Y 7Y 1.07%

FAQ About HUSSMAN STRATEGIC ADVISORS, INC. and CPRX

These are the practical questions this page is built to answer before you even open the full history table.

How long has HUSSMAN STRATEGIC ADVISORS, INC. reported owning CPRX?

HUSSMAN STRATEGIC ADVISORS, INC. reported CPRX across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported CPRX position in HUSSMAN STRATEGIC ADVISORS, INC.'s portfolio?

The largest reported portfolio weight for CPRX was 0.73% in 2025 Q2.

What is the latest reported CPRX position on this page?

The most recent filing on this page is 2026 Q1, when HUSSMAN STRATEGIC ADVISORS, INC. reported 84,000 shares, equal to 0.45% of portfolio, with an estimated market value of $2.1M.

What does the chart on this CPRX ownership page compare?

The chart compares HUSSMAN STRATEGIC ADVISORS, INC.'s quarterly CPRX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did HUSSMAN STRATEGIC ADVISORS, INC. time their CPRX position?

Based on 13F filing dates vs. subsequent CPRX price moves, HUSSMAN STRATEGIC ADVISORS, INC. correctly timed 3 out of 10 reported position changes (30%). The annualised alpha on CPRX relative to SPY over the holding period was +26.2%.

← Back to HUSSMAN STRATEGIC ADVISORS, INC. Holdings